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Abstract 
 
This study investigated the anti diarrhoeal activity of the aqueous extract of dried 
ground leaves of Eremomastax speciosa (Hochst.) Acanthaceae.  Diarrhea was induced in 
mice by the administration of 0.2 ml of castor oil, with the control group receiving water. 
The administration by oral garvage of 400 or 800 mg/kg body weight of Eremomastax 
speciosa extract reduced castor oil induced diarrheoa by reducing the number of wet stools 
by 42.50 and 48.35% respectively.  This was as a result of the ability of the extract to 
stimulate the reabsorption of water from the intestinal lumen as well as significantly 
reducing the intestinal transit time and intestinal motility.  This antidiarrhoeal property 
could be as a result of the tannins and flavonoids, which were found to be present in 
Eremomastax speciosa.  
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Introduction 
 
Traditional medical practitioners play important roles in health care delivery in 
Cameroon. However, their claims are sometimes unsubstantiated with scientific facts. 
Eremomastax speciosa (Hochst.) has been used by traditional doctors for many years as a 
haematopoietic and antidiarrhoeal herb. The stem and the leaves are used in the treatment 
of dysentery and anemia, while the aerial parts are used in the treatment of irregular 
menstruation and spurious labour pains.  The leaves are also used to treat fracture, 
hemorrhoids and urinary tract infection (Adjanohoun, et al., 1996). Eremomastax speciosa 
is a tropical stout erect multi-branched herb, which grows as a weed in secondary forests 
(Heine, 1966).  It is however cultivated by many Cameroonians as a result of its numerous  
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medicinal properties. Tan et al., (1996) reported the anti-ulcerogenic activity of 
Eremomastax speciosa. The present study was designed to study the antidiarrhoeal 
property of leaves of Eremomastax speciosa in mice. 
 
Materials and Methods 
Plant material 
 
  Fresh leaves of Eremomastax speciosa were collected in Bonamoussadi-Yaounde, 
Cameroon.  Botanic identification was performed at the Cameroon National Herbarium, 
Yaounde, Cameroon, and assigned voucher No. HNC/136984. The sample was air-dried in 
the laboratory (26 -28°C) and then ground to a powder. 
 
Preparation of plant material 
 
  The powdered sample was soaked in boiling water for 30 minutes.  The mixture 
was then allowed to cool and filtered using a glass funnel plugged with sieve cloth. The 
residue was further extracted twice with boiling water. The resulting filtrate was then 
concentrated using a rotary evaporator, and further dried in an oven at 40°C.  The resulting 
material was then stored in a refrigerator at 4°C until when required. 
 
Animals 
 
 Male mice (25-30g) obtained from the Animal Unit, Faculty of Medicine and 
Biomedical Science, University of Yaounde 1 were used for this study.  Their use was in 
conformity with regulations concerning the use of animals for experimentation in the 
University of Yaounde 1. 
 
Chemicals 
 
 Morphine (reference antidiarrhoeal drug), Castor oil (laxative agent), Charcoal 
Meal (10% activated charcoal in 5% Gum Acacia) were of pharmacological grade. All 
other reagents were of analytical grade and obtained from BDH. 
 
Phytochemical screening 
 
  The freshly prepared extract of Eremomastax speciosa was quantitatively tested for 
the presence of chemical constituents. These were identified by characteristic colour 
changes using standard procedures (Trease and Evans, 1983). 
 
Experimentally induced diarrhoea 
         The method proposed by Galvez et al., (1993) was modified to suit experimental 
needs.  
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Adult white mice fasted for 18 hours were divided into 5 groups (Group I – Group V) of 6 
animals each. The groups received the following treatment by oral garvage: Group I: 
Distilled water (0.2 ml), Group II: Morphine (25 mg/kg body weight), Group III: 
Eremomastax speciosa extract 400 mg/kg body weight, Group IV: Eremomastax speciosa 
extract 800 mg/kg body weight and Group V: Distilled water (0.2 ml). (In Groups III and 
IV, the extract was dissolved in 0.2 ml of distilled water).  Thirty minutes after the 
treatments, castor oil (0.2 ml) was administered by garvage to groups II, III, IV and V.  
 Following the administration of castor oil, the animals were placed in separate 
wired cages for observation.  The total number of faeces and the number of wet faeces 
passed was recorded over a period of 4 hours after the administration of castor oil.  The 
percentage diarrhoea inhibition was calculated as a function of the castor oil control i.e.    
% Inhibition = (control – test) x 100%/control. 
 
Upper gastrointestinal transit 
 
  The method proposed by Aye-Than et al., (1989) was used in groups of eight mice 
each, using a ‘charcoal meal’ as a marker diet. The mice were given increasing doses of 
the extract re-dissolved in 0.2 ml of distilled water by garvage.  The intestinal transit was 
calculated as a percentage of the distance travelled by the charcoal meal compared to the 
length of the small intestine.  
  
Statistical treatment of the results 
 
 The results were expressed as means ± standard deviation (SD).  Significance of 
the differences compared to the control groups was determined using the Student’s t-test. 
 
 
Table 1: Qualitative chemical analysis of Eremomastax speciosa leaf extract. 
 
Constituents Name of test  Observation  Inference 
Alkaloids Mayer’s test cream precipitate present (+ve) 
Glycosides Fehlings solution No brick-red 
precipitate 
absent (-ve) 
Cardiac glycosides Salkowski test no reddish-brown 
colour 
absent (-ve) 
Flavonoids Ammonium test Yellow colouration present (+ve) 
Saponin  Frothing test persistent foam present (+ve) 
Tannins  Ferric chloride test dark green colour present (+ve) 
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Table 2: Effect of Eremomastax speciosa leaf extract and morphine on experimentally- 
induced diarrhea in mice. 
Treatment Total number of 
faeces 
Number of wet 
faeces 
Percentage of 
inhibition 
Distilled water 16.80 ± 1.48 0.00 ± 0.00  
Castor oil (0.2 ml) 25.50 ± 2.50a 20.50 ± 3.69 0.00 
Extract (400mg/kg)  
+ Castor oil (0.2 ml) 
11.80 ± 2.20cb 12.00 ± 1.40c 42.50 
Extract (800 mg/kg)  
+ Castor oil (0.2 ml) 
12.00 ± 1.82cb 10.50 ± 1.84c 48.78 
Morphine + castor oil 
(0.2 ml) 
8.60 ± 4.20cb 0.00 ± 0.00c 100.00 
 
Results  = mean ± SD. cSignificantly lower compared with castor oil group, bsignificantly lower 
compared to normal control, aSignificantly higher than the control,  
P < 0.01 
 
Table 3: Effect of plant extract and morphine on upper gastrointestinal transit of standard charcoal 
meal in mice with castor oil induced diarrhoea. 
 
Treatment Intestinal transit (%) % Inhibition 
Distilled water control (0.2 ml) 61.72 ± 4.38  
Castor oil control (0.2 ml) 90.30 ± 7.82a  
Extract (100 mg/kg + castor oil (0.2 ml) 59.24 ± 6.76c 34.39 
Extract (200 mg/kg + castor oil (0.2 ml) 56.64 ± 7.90c 37.28 
Extract (400 mg/kg + castor oil (0.2 ml) 52.26 ± 4.36c 42.13 
Extract (800 mg/kg + castor oil (0.2 ml) 49.58 ± 3.31bc 45.09 
Morphine (25 mg/kg) + castor oil (0.2 ml) 16.03 ± 2.98bc 82.25 
 
Results are means ± standard deviation.  aSignificantly different compared to normal control, 
bsignificantly lower compared to normal control, csignificantly lower than castor oil control, p < 
0.01. 
 
Results and Discussion 
 
                    Castor oil brings about changes in electrolyte and water transport and increases 
peristaltic activity (Luderer et al., 1980; Capasso et al., 1986).  These changes are 
associated with prostaglandins that contribute to the patho-physiological functions in the 
gastro intestinal tract  (Bennet and Sanger, 1982).  Release of prostaglandins is also a 
major cause of arachidonic acid-induced diarrhoea (Luderer et al., 1980). This is 
characterized by an increase in the secretion of water and electrolytes, an increase in 
intestinal transit time and an increase in wet faeces. 
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             Table 4: Preventive and curative study of morphine and Eremomastax speciosa extract in castor   
                         oil induced diarrheal mice. 
 
Treatment Intestinal transit (%) % inhibition 
Castor oil (control, 0.2 ml) 90.30 ± 7.82  
Morphine (25 mg/kg) 30 min. before castor oil  16.03 ± 2.98c 82.25 
Morphine (25 mg/kg) 15 min after castor oil  20.00 ± 3.18c 77.85 
Extract (400 mg/kg) 30 min before castor oil  52.26 ± 4.36c 42.13 
Extract (400 mg/kg) 15 min after castor oil 58.21 ± 7.70c 35.54 
Extract (800 mg/kg) 30 min before castor oil  49.58 ± 3.31c 45.09 
Extract (800 mg/kg) 15 min. after castor oil 51.34±2.45c 43.10 
 
Results are means ± SD. cSignificantly lower compared to castor oil control, P < 0.01 
 
The aqueous extract of Eremomastax speciosa leaves showed significant antidiarrhoeal 
activity (P<0.01) against castor oil induced diarrhoea in mice. It reduced the number of wet 
faeces produced by castor oil administration from 20.50 ± 3.69 to 12.00±1.40 (42.50%) 
and 10.50 ± 1.84 (48.75%) when experimental animals were respectively administered 
400 and 800 mg/kg plant extract (Table 2).  The plant extract thus stimulates the 
reabsorption of water from the intestinal lumen, resulting to the normalisation of the 
deranged water transport across the mucosal cells which are seen in the type of faeces 
produced. 
 Administration of castor oil to experimental animals stimulated small intestinal 
transit of 90.30 ± 7.82. Administration of Eremomastax speciosa demonstrated a 
significant (P < 0.01) dose related reduction of this intestinal transit (Table 3) with 800 
mg/kg being more effective than the lower dose of extract. This activity is probably due to 
the ability of the extract to inhibit intestinal motility. 
 Administration of the Eremomastax speciosa extract and morphine, 30 minutes 
before (preventive) or 15 minutes after (curative) castor oil administration, significantly (P 
< 0.01) decreased the intestinal transit time (Table 4). The reduction of the intestinal transit 
following administration of the Eremomastax speciosa extract before and after the onset of 
castor oil-induced gut movement demonstrated the ability of the extract to protect the gut 
from the adverse effect of diarrhoea and the ability to suppress established gut motility 
respectively. Morphine (25 mg/kg) was more effective as an antidiarrheal agent than the 
plant extract even when experimental animals were administered an 800 mg/kg dose of the 
plant extract.  Morphine is a prototypical antidiarrhoeal drug, which acts on the 
gastrointestinal tract, and mediates both central and local effects (Galligan and Burks, 
1983; Megens, 1990).  It stimulates the net absorption of water and electrolytes in the 
small and large intestine in several species of animals, including man (Couper, 1987). 
Similar results were obtained in our study in which morphine (25 mg/kg) stimulated the 
reduction of the intestinal transit time and brought about a complete (100%) inhibition of 
the onset of diarrhoeal faeces (Tables 2, 3, 4). Phytochemical screening of the crude 
extract of Eremomastax speciosa revealed the presence of tannins and flavonoids (Table 
1), which 
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have been shown to possess antidiarrhoeal activity (Galvez et al., 1991, 1993). Thus, 
tannins and flavonoids may be responsible for the antidiarrheal activity of Eremomastax 
speciosa by stimulating the normalization of the deranged water transport across the 
mucosal cells and the reduction of the intestinal transit, which have more useful 
therapeutic effects than any action on intestinal motility and propulsion. 
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